Performance highlights
Adjusted pre-tax profit up 8.2%
Over £90m invested in capital projects to drive future growth
Proposed special capital return of 100p per share
Sales value


Adjusted pre-tax profit


Free cash flow


Sales by market sector (£m)


Group sales
Personal Care
Life Sciences
Performance Technologies
Industrial Chemicals

We are a strong cash generator with a disciplined approach to capital spend, investing in technology and capacity to meet customer demand, whilst also returning cash to shareholders."
Jez Maiden
Group Finance Director